ABNOVA (TAIWAN) CORPORATION. Inactive Instrument
Abnova (Taiwan) Corporation. Share Price Taipei Exchange
Equities
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - TWD | - |
|
| 05-09 | Abnova Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-08 | Abnova Corporation Announces Establishment of Risk Management Committee | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 412M 12.71M 1B | Sales 2023 | 382M 11.79M 929M | Capitalization | 2.13B 65.6M 5.17B |
|---|---|---|---|---|---|
| Net income 2022 | 74M 2.28M 180M | Net income 2023 | 43M 1.33M 105M | EV / Sales 2022 | 5.2 x |
| Net cash position 2022 | 356M 10.98M 865M | Net cash position 2023 | 415M 12.82M 1.01B | EV / Sales 2023 | 4.48 x |
| P/E ratio 2022 |
33.5
x | P/E ratio 2023 |
48.8
x | Employees | - |
| Yield 2022 |
1.94% | Yield 2023 |
2.05% | Free-Float | 75.68% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Pei Ju Jih
CEO | Chief Executive Officer | - | 30/06/18 |
Wilber Huang
CHM | Chairman | 58 | - |
I Ling Tung
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yueh Hung Chen
BRD | Director/Board Member | 60 | 18/06/20 |
Wilber Huang
CHM | Chairman | 58 | - |
Jia Hsie Lin
BRD | Director/Board Member | 73 | 22/06/17 |
ABNOVA (TAIWAN) CORPORATION is a Taiwan-based company principally engaged in the manufacturing and sales of antibodies and proteins. The Company's products mainly include monoclonal antibodies, polyclonal antibodies, protein fragments, full-length proteins, active proteins, antibody pairs, fluorescence in situ hybridization probe and others. The Company's monoclonal and polyclonal antibodies are primarily applied in medical testing reagents, agricultural testing, industrial purification, medical treatment and other fields. Its proteins are mainly applied in medical testing reagents, agricultural testing, medical treatment, protein engineering and other fields. Its products are mainly traded in Taiwan, Americas and Europe.
Calendar
06/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +16.42% | 122B | |
| +19.02% | 113B | |
| +3.06% | 22.66B | |
| -11.63% | 16.68B | |
| -16.31% | 16.61B | |
| -39.57% | 16.92B | |
| +2.68% | 13.62B | |
| +21.16% | 11.04B | |
| +108.78% | 10.43B |
